重度主动脉瓣狭窄合并重度二尖瓣狭窄一站式治疗1例

胡彩娜; 李光照; 王明蛟; 姜正明

doi:10.13201/j.issn.1001-1439.2021.09.018

重度主动脉瓣狭窄合并重度二尖瓣狭窄一站式治疗1例

- 郑州大学第一附属医院心内科(郑州, 450002)

详细信息

通讯作者: 姜正明,E-mail:2524231099@qq.com

中图分类号: R542.5

收稿日期: 2020-12-30

One-stop treatment of severe aortic valve stenosis combined with severe mitral valve stenosis: one case report

- Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450002, China

More Information

Corresponding author: JIANG Zhengming, E-mail: 2524231099@qq.com

Received Date: 30 December 2020

摘要

- 主动脉瓣狭窄 /
- 二尖瓣狭窄 /
- 经导管主动脉瓣置换术 /
- 经皮球囊二尖瓣成形术
Abstract: At present, TAVR has gradually matured in the treatment of aortic valve stenosis, but the clinical risk and benefit of TAVR treatment for aortic stenosis combined with other diseases is difficult to analyze, which is still a major clinical problem facing the development of TAVR. Here is a case of successful TAVR treatment in severe aortic valve stenosis with severe mitral valve stenosis.
- aortic valve stenosis /
- mitral valve stenosis /
- transcatheter aortic valve replacement /
- percutaneous balloon mitral valvuloplasty

HTML全文

参考文献(14)

[1]	Osnabrugge RL,Mylotte D,Head SJ,et al.Aortic stenosis in the elderly:disease prevalence and number of candidates for transcatheter aortic valve replacement:a meta-analysis and modeling study[J].J Am Coll Cardiol,2013,62(11):1002-1012.
[2]	Pan W,Zhou D,Cheng L,et al.Candidates for transcatheter aortic valve implantation may be fewer in China[J].Int J Cardiol,2013,168(5):e133-134.
[3]	Siontis G,Overtchouk P,Cahill TJ,et al.Transcatheter aortic valve implantation vs.surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis:an updated meta-analysis[J].Eur Heart J,2019,40(38):3143-3153.
[4]	李光照,王明蛟,胡彩娜,等.经导管主动脉瓣置换术治疗重度主动脉瓣狭窄的初步临床疗效分析[J].临床心血管病杂志,2020,36(3):280-283.
[5]	Asami M,Windecker S,Praz F,et al.Transcatheter aortic valve replacement in patients with concomitant mitral stenosis[J].Eur Heart J,2019,40(17):1342-1351.
[6]	Vollenbroich R,Stortecky S,Praz F,et al.The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation[J].Am Heart J,2017,184:71-80.
[7]	Unger P,Tribouilloy C.Aortic stenosis with other concomitant valvular disease:aortic regurgitation,mitral regurgitation,mitral stenosis,or tricuspid regurgitation[J].Cardiol Clin,2020,38(1):33-46.
[8]	Ellis LB,Singh JB,Morales DD,et al.Fifteen-to twenty-year study of one thousand patients undergoing closed mitral valvuloplasty[J].Circulation,1973,48(2):357-364.
[9]	Vallabhajosyula S,Patlolla SH,Sandhyavenu H,et al.Periprocedural cardiopulmonary bypass or venoarterial extracorporeal membrane oxygenation during transcatheter aortic valve replacement:A systematic review[J].J Am Heart Assoc,2018,7(14):120.
[10]	Higuchi R,Tobaru T,Hagiya K,et al.Outcomes of patients requiring extracorporeal membrane oxygenation in transcatheter aortic valve implantation:a clinical case series[J].Heart Vessels,2018,33(11):1343-1349.
[11]	中国医师协会心血管内科医师分会结构性心脏病专业委员会.经导管主动脉瓣置换术中国专家共识(2020更新版)[J].中国介入心脏病学杂志,2020,28(6):301-309.
[12]	Thirumala PD,Muluk S,Udesh R,et al.Carotid artery disease and periprocedural stroke risk after transcatheter aortic valve implantation[J].Ann Card Anaesth,2017,20(2):145-151.
[13]	Kumar N,Khera R,Fonarow GC,et al.Comparison of outcomes of transfemoral versus transapical approach for transcatheter aortic valve implantation[J].Am J Cardiol,2018,122(9):1520-1526.
[14]	Caceres M,Braud R,Roselli EE.The axillary/subclavian artery access route for transcatheter aortic valve replacement:a systematic review of the rature[J].Ann Thorac Surg,2012,93(3):1013-1018.